My watch list
my.bionity.com  
Login  

Helmholtz-Zentrum für Infektionsforschung GmbH

Inhoffenstraße 7
38124 Braunschweig
Germany
Tel.
+49 531 6181-0
Fax
+49 531 6181-2655

www.helmholtz-hzi.de/de/

Short description

How do bacteria, viruses, parasites and fungi make us sick? How does our immune system defend our body? These are the questions we at the HZI want to answer. Our goal: To set up the basis for new diagnostic tools, new active agents and new therapies against infectious diseases. Together with 150 guest scientists from all over the world, our researchers take on this urging task. With sophisticated laboratory techniques they observe pathogens and immune cells during the moment of infection. They analyse the molecular structure of the “weapons” that pathogen utilise to invade a host cell – and develop methods to defuse them. They seek for substances from the nature and the lab that neutralise pathogens, prevent infections or are even able to cure them. They use high tech analytical devices and study the processes of infections in cell culture, in complex, elaborate computer simulations, and in mice – for a healthier future.

More about Helmholtz-Zentrum für Infektionsforschung
  • News

    Predicting slippery spots for the ribosome

    In the genetic blueprint for proteins, the information for each amino acid is encoded by codons. A codon consists of three consecutive building blocks of messenger RNA (mRNA), a base triplet that encodes exactly one amino acid. During protein synthesis, adaptor molecules - called tRNAs - sp ... more

    From cancer medication to antibiotic

    Antibiotic-resistant bacteria are increasingly the source of deadly infections. A team of scientists from the Technical University of Munich (TUM) and the Helmholtz Center for Infection Research (HZI) in Braunschweig have now modified an approved cancer drug to develop an active agent again ... more

    Super-antibody strategy for universal vaccines

    New influenza vaccines are required every autumn, because the viruses constantly change the components to which our immune protection responds. Medical research is focusing on universal vaccines that target more stable parts of the viruses. This new generation of broadly neutralising antibo ... more

  • Companies

    Helmholtz-Zentrum für Infektionsforschung GmbH

    As a Helmholtz centre for infectious diseases, the main focus of the GBF research activities is to study microbial virulence factors, host-pathogen interactions, and immunity to develop strategies for the diagnosis, prevention and therapy of human infectious diseases. In addition, the GBF B ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE